Novartis AG
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections

Last updated:

Abstract:

The invention provides compounds of Formula (I): ##STR00001## as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.

Status:
Grant
Type:

Utility

Filling date:

25 Aug 2017

Issue date:

24 Aug 2021